For the Inventor, By the Inventor

Enter assignee name

Hellerup, Denmark

Union Therapeutics A/s

USPTO Granted Patents = 22

EPO Patents = 14

Forward Citations = 75

Loading Chart...

Loading Chart...

46 inventors (with patents filed for the assignee):

Morten Otto Alexander Sommer (12 out of 13 patents)

Rasmus Vendler Toft-Kehler (9 out of 10 patents)

Daniel Jean Jacques Simon (7 out of 8 patents)

4. Jens Larsen (4 out of 8 patents)

5. Emilie Flora Aurore Delavenne (4 out of 5 patents)

6. Mark Andrews (3 out of 5 patents)

7. Allan Carsten Dahl (3 out of 3 patents)

8. Daniel Rodriguez Greve (3 out of 14 patents)

9. Anne Katrine Toft-Kehler (2 out of 2 patents)

10. Mads Jellingsoe (2 out of 2 patents)

11. Günter Ditzinger (2 out of 2 patents)

12. Philippe Andres (2 out of 2 patents)

13. Matthias Manne Knopp (2 out of 2 patents)

14. Johan Eriksson Bajtner (2 out of 2 patents)

15. Esben Paul Krogh Olsen (2 out of 2 patents)

22 patents: Sort by Forward Citations

1. 12409172 - Dosage regimen (2025-09-09),

2. 12084457 - Methods for the preparation of 1,3-benzodioxole heterocyclic compounds (2024-09-10),

3. 12036312 - Non-aqueous topical compositions comprising a halogenated salicylanilide (2024-07-16),

4. 11981681 - Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors (2024-05-14),

5. 11866445 - Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors (2024-01-09),

6. 11529361 - Halogenated salicylanilides for treatinginfections (2022-12-20),

7. 11384096 - Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors (2022-07-12),

8. 11370799 - Methods for the preparation of 1,3-benzodioxole heterocyclic compounds (2022-06-28),

9. 11365204 - Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors (2022-06-21),

10. 11331327 - Antibacterial use of halogenated salicylanilides (2022-05-17),

11. 11331289 - Antimicrobial composition (2022-05-17),

12. 11324761 - Antibacterial use of halogenated salicylanilides (2022-05-10),

13. 11324708 - Niclosamide formulations for treating disease (2022-05-10),

14. 11299497 - Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors (2022-04-12),

15. 11292799 - Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors (2022-04-05),

UNION therapeutics A/S is a pharmaceutical company specializing in the development of novel medications to treat inflammatory and infectious diseases. With a focus on the respiratory system, UNION is committed to improving the lives of patients through innovative therapeutic solutions. Through extensive research and clinical trials, the company aims to discover safe and effective treatments with the potential to revolutionize healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

22 Patents

#2 in Hellerup

#134 in Denmark

#27,846 in the World

Hellerup, Denmark

Union Therapeutics A/s

Forward Citations = 75

46 inventors:

Morten Otto Alexander Sommer (12 out of 13 patents)

Rasmus Vendler Toft-Kehler (9 out of 10 patents)

Daniel Jean Jacques Simon (7 out of 8 patents)

4. Jens Larsen (4 out of 8 patents)

5. Emilie Flora Aurore Delavenne (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…